322 related articles for article (PubMed ID: 6191171)
1. [Interferon--the prospects and problems of its use in therapeutic and oncological practice].
Poverennyĭ AM
Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171
[No Abstract] [Full Text] [Related]
2. Interferons and interferon inducers in cancer treatment.
Krown SE
Semin Oncol; 1986 Jun; 13(2):207-17. PubMed ID: 2424089
[No Abstract] [Full Text] [Related]
3. [Interferon].
Vargas Vorackova F; Mata Mendoza JM
Rev Invest Clin; 1981; 33(4):419-25. PubMed ID: 6173909
[No Abstract] [Full Text] [Related]
4. Interferon induction and suppression of solid tumor growth in rats by tilorone hydrochloride.
Rhoads AR; West WL; Morris HP
Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):741-50. PubMed ID: 4356214
[No Abstract] [Full Text] [Related]
5. [The medical significance of interferons and their inducers].
Ershov FI
Vestn Ross Akad Med Nauk; 2004; (2):9-13. PubMed ID: 15101201
[TBL] [Abstract][Full Text] [Related]
6. Interferon: a perspective.
Weissman RM; Droller MJ
Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
[No Abstract] [Full Text] [Related]
7. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
8. Interferon and interferon inducers in the treatment of malignancies.
Levy HB
Arch Intern Med; 1970 Jul; 126(1):78-83. PubMed ID: 5425518
[No Abstract] [Full Text] [Related]
9. Interferon as therapeutic agent.
Borecký L; Fuchsberger N
Acta Virol; 1983 Jul; 27(4):359-70. PubMed ID: 6195902
[TBL] [Abstract][Full Text] [Related]
10. [Antiviral properties of polynucleotides not associated with interferon induction].
Shved AD
Mikrobiol Zh (1978); 1982; 44(3):75-85. PubMed ID: 6181384
[No Abstract] [Full Text] [Related]
11. Antitumor action of pyran copolymer and tilorone against Lewis lung carcinoma and B-16 melanoma.
Morahan PS; Munson JA; Baird LG; Kaplan AM; Regelson W
Cancer Res; 1974 Mar; 34(3):506-11. PubMed ID: 4812258
[No Abstract] [Full Text] [Related]
12. [The interferon system with special reference to gamma-interferons].
Kirchner H
Dtsch Med Wochenschr; 1986 Jan; 111(2):64-70. PubMed ID: 2416525
[No Abstract] [Full Text] [Related]
13. [Perspectives on interferon research and on its therapeutic use].
Montagnier L
Arch Inst Pasteur Tunis; 1981; 58(3):297-312. PubMed ID: 6172080
[TBL] [Abstract][Full Text] [Related]
14. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
15. [Progress in virology. 5. Interferon].
Presber HW; Waschke SR
Z Arztl Fortbild (Jena); 1981 Mar; 75(6):277-85. PubMed ID: 6169208
[No Abstract] [Full Text] [Related]
16. Natural killer cells and naturally occurring antibodies as representatives of natural tumor immunity.
Ehrlich R; Witz IP
Pathobiol Annu; 1982; 12():85-113. PubMed ID: 6186979
[No Abstract] [Full Text] [Related]
17. Interferon and ocular virus disease.
Raju VK
Indian J Ophthalmol; 1984; 32(5):429-31. PubMed ID: 6085834
[No Abstract] [Full Text] [Related]
18. The natural killer cell-interferon system in human carcinoma--its relation to interferon cancer treatment trials.
Ching NP; Ching CY; Jim EL; Loh KK; Oishi N; Yim DW
Hawaii Med J; 1984 Oct; 43(10):368-72. PubMed ID: 6210268
[No Abstract] [Full Text] [Related]
19. [Interferon and its inducers].
de Maeyer-Guignard J
Rev Prat; 1979 Aug; 29(37):2929-33. PubMed ID: 118508
[No Abstract] [Full Text] [Related]
20. [Human interferons -- features and chances (author's transl)].
Pohl A; Moser K; Micksche M
Wien Klin Wochenschr; 1981 Jul; 93(14):439-57. PubMed ID: 6168122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
